LYRA
Lyra Therapeutics, Inc. · Healthcare
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$535K
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
May 15, 2026
Palasis Maria
Lyra Therapeutics, Inc. (LYRA) has 7 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: May 15, 2026.
Inside the rolling window, 3 insiders at Lyra Therapeutics, Inc. reported no open-market purchases and 8 open-market sales totaling $535K. The most active filer is 10% Owner PERCEPTIVE ADVISORS LLC with 6 filings. The most recent open-market filing is a sale of 1,702 shares by President & CEO Palasis Maria, dated Jan 6, 2026, worth $6K.
- Industry:Biotechnology
- CEO:Carmichael S. Roberts Jr.
- Employees:27
- HQ:Watertown, MA, US
- IPO:2020-05-01
| Source | |||||||
|---|---|---|---|---|---|---|---|
| President & CEO | Sale | 1,702 | $6K | Jan 8 | -93.4% | SEC ↗ | |
Cavalier JasonFirst filing | Chief Financial Officer | Sale | 769 | $3K | Jan 8 | -93.4% | SEC ↗ |
| 10% Owner | Sale | 5,320 | $23K | Nov 13 | -93.5% | SEC ↗ | |
| 10% Owner | Sale | 8,745 | $35K | Nov 13 | -93.5% | SEC ↗ | |
| 10% Owner | Sale | 31,810 | $124K | Nov 13 | -93.5% | SEC ↗ | |
PERCEPTIVE ADVISORS LLCFirst filing | 10% Owner | Sale | 32,149 | $167K | Nov 10 | -94.3% | SEC ↗ |
PERCEPTIVE ADVISORS LLCFirst filing | 10% Owner | Sale | 19,739 | $94K | Nov 10 | — | SEC ↗ |
PERCEPTIVE ADVISORS LLCFirst filing | 10% Owner | Sale | 18,502 | $84K | Nov 10 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does LYRA have?
Lyra Therapeutics, Inc. (LYRA) has 7 SEC Form 4 filings (17 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: May 15, 2026.
When was the most recent SEC Form 4 filing for LYRA?
The most recent Form 4 filing for LYRA on Tracefour is dated May 15, 2026.
Who is the most active insider at LYRA?
The most active SEC Form 4 filer at LYRA in the rolling window is 10% Owner PERCEPTIVE ADVISORS LLC, with 6 filings.
What is the net insider flow at LYRA over the last 6 months?
Over the trailing 180 days, insiders at LYRA have net sold $8K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at LYRA in the current window?
Inside the rolling window, insiders at LYRA bought $0 and sold $535K based on SEC Form 4 filings.
Can I get alerts for LYRA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Lyra Therapeutics, Inc. (LYRA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Lyra Therapeutics, Inc. is in the Healthcare sector.